Toxic epidermal necrolysis 2006

Journal of the American Academy of Dermatology

Volumn 55, Issue 5, 2006, Pages 867-869

  Heymann, Warren R ^a  

^a Based on the dialogue Dermatologic emergencies with Paul A Krusinski   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHETAMINE; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CARBAMAZEPINE; CORTICOSTEROID; ELECTROLYTE; FAS LIGAND; HLA B ANTIGEN; IMATINIB; IMMUNOGLOBULIN; LAMOTRIGINE; NONSTEROID ANTIINFLAMMATORY AGENT; PERFORIN; RITUXIMAB; SULFAMETHOXAZOLE; SULFONAMIDE; TETRAZEPAM; TRIMETHOPRIM; TUMOR NECROSIS FACTOR ALPHA; VORICONAZOLE;

ANTIMICROBIAL THERAPY; APOPTOSIS; ARTICLE; BLISTER; BURN UNIT; CD8+ T LYMPHOCYTE; DERMATOLOGY; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG MEGADOSE; GENETIC PREDISPOSITION; HEALTH SURVEY; HOMEOSTASIS; HOSPITAL ADMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MAINTENANCE THERAPY; MORBIDITY; MORTALITY; MOUTH HYGIENE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PRURITUS; SECRETION; SKIN BIOPSY; SKIN CARE; STEVENS JOHNSON SYNDROME; SUPERINFECTION; TEMPERATURE; TOXIC EPIDERMAL NECROLYSIS; WOUND DRESSING;

EMERGENCIES; EPIDERMAL NECROLYSIS, TOXIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS;

EID: 33750046955     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.06.041     Document Type: Article

References (16)

1. Freiman A., Borsuk D., and Sasseville D. Dermatologic emergencies. CMAJ 173 (2005) 1317-1319
2. Varghese S.P., Haith L.R., Patton M.L., Guilday R.E., and Ackerman B.H. Lamotrigine-induced toxic epidermal necrolysis in three patients treated for bipolar disorder. Pharmacotherapy 26 (2006) 699-704
3. Delesalle F., Carpentier O., Gautier S., and Delaporte E. Toxic epidermal necrolysis caused by tetrazepam. Int J Dermatol 45 (2006) 480
4. Scheinfeld N. A review of rituximab in cutaneous medicine. Dermatol Online J 12 (2006) 3
5. Scheinfeld N. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate. J Drugs Dermatol 5 (2006) 228-231
6. Curigliano G., Formica V., De Pas T., Spitaleri G., Pietri E., Fazio N., et al. Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy. Ann Oncol 17 (2006) 1174-1175
7. Roberts H., Chamberlain A., Rennick G., McLean C., and Gin D. Severe toxic epidermal necrolysis precipitated by amphetamine use. Australas J Dermatol 47 (2006) 114-116
8. Gimnig J.E., MacArthur J.R., M'bang'ombe M., Kramer M.H., Chizani N., Stern R.S., et al. Severe cutaneous reactions to sulfadoxine-pyramethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi. Am J Trop Med Hyg 74 (2006) 738-743
9. Aguemon A.R., Houngbe F., Yameogo T.M., Tchaou B., Madougou S., Lokossou T., et al. Toxic epidermal necrolysis. Epidemiologic, clinic and therapeutic aspects at Cotonou University and national teaching hospital. Ann Fr Anest Reanim 25 (2006) 505-509
10. Hung S.I., Chung W.H., Jee S.H., Chen W.C., Chang Y.T., Lee W.R., et al. Genetic susceptibility to carbemazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 16 (2006) 297-306
11. French L.E., Trent J.T., and Kerdel F.A. Use of intravenous iummunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Int Immunopharmacol 6 (2006) 543-549
12. Lan C.C., Wu C.S., Tsai P.C., and Chen G.S. Diagnostic role of soluble Fas ligand secretion by peripheral blood mononuclear cells from patients with previous drug-induced blistering disease: a pilot study. Acta Derm Venereol 86 (2006) 215-218
13. Roujeau J.C., Gelard K., and Bensussan A. Epidermal necrolysis: mechanisms of keratinocyte apoptosis. Med Sci (Paris) 22 (2006) 188-191
14. Caproni M., Torchia D., Schincaglia E., Volpi W., Frezzolini A., Schena D., et al. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Br J Dermatol 154 (2006) 319-324
15. Paquet P., Kaveri S., Jacob E., Pirson J., Quatresooz P., and Pierard G.E. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis. Exp Dermatol 15 (2006) 381-386
16. Craven N. Toxic epidermal necrolysis and Stevens-Johnson syndrome. In: Lebwohl M.G., Heymann W.R., Berth-Jones J., and Coulson I. (Eds). Treatment of skin disease (2006), Mosby/Elsevier, London 657-660